Nearly one year after the Ann Arbor, Michigan City Council voted to decriminalize a wide-range of psychedelics, lawmakers on Monday approved a resolution to officially designate September as Entheogenic Plants and Fungi Awareness Month.
Articles
Poll: Nearly Half of U.S. Adults Have Tried Cannabis
Nearly half of U.S. adults—49%—have tried cannabis, according to a Gallup poll, which also found 12% of U.S. adults use it regularly.
Cybin Files 14th Patent Application Further Strengthening its IP Portfolio and Receives a Favorable Patent Claim Opinion
Cybin announces the filing of a non-provisional patent application, the company's 14th patent application.
MindMed Joins Critical Path Institute's Patient-Reported Outcome Consortium
MindMed announces joining a research consortium, the Patient-Reported Outcome Consortium, to assist in its mission to advance medical innovation.
PharmaCann Planning IPO with Potential Valuation of $1B+
New York-based cannabis firm PharmaCann is planning an initial public offering that could value the company at over $1 billion, according to a Reuters report citing sources familiar with the plan.
Psychedelic Toad Venom Clinical Research Boosted by $80M in Funding
Oxford-based startup Beckley Psytech in the United Kingdom announced August 15 that it raised $80 million to ramp up clinical trials and research using a pharmaceutical formulation of 5-MeO-DMT, a powerful compound produced endogenously by Sonoran Desert toad venom, to treat depression.
MindMed Announces 2021 Q2 Financial Results; Cash Balance of $157 USD Million ($195 CAD Million) to Execute on Diverse Clinical Pipeline
MindMed reports a Q2 2021 loss of $36 million. Current cash on hand of $157 million.
GOP Congressman Who Voted Against Psychedelics Amendment Says MDMA Therapy ‘Sounds Amazing’
A Republican congressman who’s voted against modest measures to loosen barriers on psychedelic research seems to be coming around on the issue following discussions with advocates—including military veterans who have utilized the substances therapeutically—and now says the treatment “sounds amazing.”
Wisconsin Lawmakers Push to Legalize Cannabis
Wisconsin Senator Melissa Agard wants to finally legalize marijuana in Wisconsin.
Is Access To Psychedelic Medicine The Largest Human Rights Issue Today?
The Mental Health Crisis is now a mental health pandemic. Is access to psychedelic medicine the world's largest human rights issue?
These States Could Have Marijuana And Psychedelics Legalization On The Ballot In 2022
Marijuana reform has advanced in numerous state legislatures in the first half of 2021, with lawmakers enacting four new legalization laws so far this year.
atai Launches Revixia Life Sciences to Develop Salvinorin A for a Variety of Mental Health Conditions
ATAI's newest research partner, Revixia Life Sciences, is seeking to treat depression and substance abuse with Salvinorin A, a lesser-known psychedelic used by indigenous peoples.
COMPASS Pathways plc announces financial results and business highlights for the second quarter 2021
Compass Pathways reports a Q2 loss of $17.5 million and announces raising $154.8 million in a new financing in May.
Wesana Health Commences Functional Animal Study for Treatment of Traumatic Brain Injury
Wesana Health announces the commencement of pre-clinical psychedelics research for Traumatic Brain Injury.
Cannabis Research Provisions Included in Senate-Approved Infrastructure Bill
Included in the $1.2 trillion infrastructure bill are provisions that would let researchers study cannabis from state-licensed dispensaries instead of the low-grade cannabis grown at government facilities.